Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis
Crossref DOI link: https://doi.org/10.1007/s10549-015-3643-5
Published Online: 2015-11-23
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Adunlin, George
Cyrus, John W. W.
Dranitsaris, George
Text and Data Mining valid from 2015-11-23